CIK 0001762303 · Non-accelerated filer<br>Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202578762
- Phone
- 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-21 | Shiroma Donna General Counsel | Sale | −4,193 | $15.84 | $66K | 42,257 |
| 2023-08-16 | O'Toole David D CFO | Purchase | +1,000 | $17.05 | $17K | 8,000 |
| 2023-08-16 | O'Toole David D CFO | Purchase | +1,000 | $17.06 | $17K | 9,000 |
| 2023-08-15 | O'Toole David D CFO | Purchase | +1,000 | $17.92 | $18K | 3,000 |
| 2023-08-15 | O'Toole David D CFO | Purchase | +1,000 | $17.89 | $18K | 4,000 |
| 2023-08-15 | O'Toole David D CFO | Purchase | +1,000 | $17.96 | $18K | 5,000 |
| 2023-08-15 | O'Toole David D CFO | Purchase | +1,000 | $17.94 | $18K | 6,000 |
| 2023-08-15 | O'Toole David D CFO | Purchase | +1,000 | $17.93 | $18K | 7,000 |
| 2023-06-20 | O'Toole David D CFO | Purchase | +1,000 | $16.15 | $16K | 2,000 |
| 2023-06-15 | O'Toole David D CFO | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2023-06-06 | Vance Cary Guy Director | Grant or award | +10,374 | 10,374 | ||
| 2023-06-06 | Vance Cary Guy Director | Grant or award | +6,175 | 16,549 | ||
| 2023-06-06 | Vance Cary Guy Director | Grant or award · Stock Options (Right to Buy) | +4,446 | 4,446 | ||
| 2023-06-06 | Vance Cary Guy Director | Grant or award · Stock Options (Right to Buy) | +2,646 | 2,646 | ||
| 2023-06-06 | Shiroma Donna General Counsel | Grant or award · Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2023-06-06 | REED JAN STERN Director | Grant or award | +6,175 | 31,789 | ||
| 2023-06-06 | REED JAN STERN Director | Grant or award · Stock Options (Right to Buy) | +2,646 | 2,646 | ||
| 2023-06-06 | Quick Andrew Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2023-06-06 | Panaccio Lou Director | Grant or award | +6,175 | 37,206 | ||
| 2023-06-06 | Panaccio Lou Director | Grant or award · Stock Options (Right to Buy) | +2,646 | 2,646 |
Page 6 of 10 · 185 trades